MPH Mittelständische Pharma Holding AG / Interim Report 22.10.2009 Dissemination of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer / publisher is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Today, 22 October 2009, MPH Mittelständische Pharma Holding AG publishes interim results as at 30 September 2009. Results of MPH Group are fully affected by HAEMATO PHARM AG (100% subsidiary). Interim Group accounts were not drawn up. Due to this, all key figures following are those of HAEMATO PHARM AG (according to German Commercial Code, HGB). Within the first nine month 2009, HAEMATO PHARM AG achieved revenues of EUR 40.8 million. Revenues resulted by manufacturing and selling of pharmaceuticals to pharmacies and to distributors working in this segment. Compared to the first nine month 2008, revenues came up by more than 500 percent. Approximately 44 percent or EUR 18 million of revenues relate to the third quarter 2009. Reporting periods EBIT came to EUR 2.7 million About MPH Mittelständische Pharma Holding AG: Berlin based MPH Mittelständische Pharma Holding AG is an investment company within the pharmaceutical/healthcare sector. Core segments are parallel imports (currently focussing oncology, rheumatology and HIV), generic medicaments and wholesaling. Based on strong growth, in 2009 it was possible to increase the number of employees from 13 (30 September 2008) up to 31 (30 September 2009). All employees are working in Berlin-Schönefeld. In this region, MPH is one of the few companies clearly creating new jobs. Since 1 September 2009, MPH Mittelständische Pharma Holding AG is listed in the Open Market of Frankfurt stock exchange. Key figures to the MPH share: |[![CDATA[|[pre|]]]|] Capital stock EUR 38,050,000 Listed class of shares Bearer preferred share Number of outstanding preferred shares 19,025,000 ISIN DE000A0NF697 Ticker symbol 93MV Freefloat 2 percent* Designated Sponsor Close Brothers Seydler Bank AG |[![CDATA[|[/pre|]]]|] * re-placement of stake of major shareholder Magnum AG in preparation bonnIR Hubert Bonn Telefon: +49 (0)6157 9861190 Mailto: bonn@bonn-ir.com 22.10.2009 |[![CDATA[|[a href="http://www.dgap.de"|]Financial News transmitted by DGAP|[/a|]]]|] ---------------------------------------------------------------------------
DGAP-News: MPH Mittelständische Pharma Holding AG: Interim results showing success in growth
| Source: EQS Group AG